Proficio Capital Partners LLC Alkermes Plc. Transaction History

Proficio Capital Partners LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$19.51 - $24.28 $10,184 - $12,674	-522 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$21.47 - $37.33 $10,284 - $17,881	479 Added 1113.95%	522 $12,000
Q1 2019 May 13, 2019	SELL	$28.4 - $36.49 $710 - $912	-25 Reduced 36.76%	43 $2,000
Q4 2018 Feb 08, 2019	BUY	$27.94 - $44.61 $1,285 - $2,052	46 Added 209.09%	68 $2,000
Q3 2018 Nov 13, 2018	SELL	$38.6 - $46.12 $2,856 - $3,412	-74 Reduced 77.08%	22 $1,000
Q2 2018 Aug 10, 2018	SELL	$40.56 - $51.36 $5,516 - $6,984	-136 Reduced 58.62%	96 $4,000
Q1 2018 May 14, 2018	BUY	$53.61 - $67.26 $2,573 - $3,228	48 Added 26.09%	232 $13,000
Q4 2017 Feb 09, 2018	BUY	$47.69 - $55.39 $6,724 - $7,809	141 Added 327.91%	184 $10,000
Q3 2017 Nov 14, 2017	BUY	$49.16 - $54.45 $2,113 - $2,341	43	43 $2,000

362

181M

175K

96.6K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.9B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Proficio Capital Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Proficio Capital Partners LLC with notifications on news.